Virtual Events

Join us for Inning 1 of the Bullpen virtual meeting series entitled “Deal Structure”

Hour 1: Panel Discussion

The life sciences game changes constantly and so do deal structures. Keep your finger on the pulse of the market in the Bullpen.

This one-hour Panel Discussion will highlight 5-10 top advisors, bankers, investors, brokers and strategics who are closing deals today ranging from seed round to IPOs, commercial leases to licenses.

Each panelist will share real-time insights into their deal flow structure and what is driving it.

Join us for Inning 2 of the Bullpen virtual meeting series entitled “Pitch Deck.”

Hour 1: Panel Discussion

Hey Pitchers - how confident are you in your delivery? What deck do you send for your first pitch? Are you sure it’s what investors want to see?

This one-hour Panel Discussion will highlight 5-10 top investors active in seed to late-stage deals. They will critique and rank four volunteer Club Member’s intro decks. Bring your peanuts and Cracker Jack to this one.

Each panelist will share what they hope to see in an intro deck and how much time they are willing to give your idea.

Join us for Inning 3 of the Bullpen virtual meeting series entitled “Industry Partnering.”

Hour 1: Panel Discussion

Deal Makers deliver results for many different types of teams within life sciences. This week, we introduced you to several who are building the path forward by bringing us together.

This one-hour Panel Discussion highlighted 18 top accelerators, associations, non-profits, strategics, government agencies and industry groups that bring partnerships together.

Each panelist shared their unique approach and value they offer to the market.

Join us for Inning 4 of the Bullpen virtual meeting series entitled “Non-Dilutive Funding.”

Non-Dilutive Funding is the warm up exercise for many life science startups…and it can come from many different sources. It puts the technology players on the field to be evaluated by the scouts.

This one-hour Panel Discussion will highlight 10+ top advisors, nonprofits and government agencies that bring equity-free funding to some of the world’s most exciting life science startups.

Each panelist will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook. Angels are the leadoff investors that pitchers face in the life sciences game. Our panelists will share what compels them as Angels to divinely invest early in promising technologies and people. This one-hour Panel Discussion will feature Angel Investors willing to get the game started for some of the world’s most exciting startups in Drugs, Device, Diagnostics, Digital, Tools & Services. Each investor will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook. Each panelist will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Venture Investors swing for the fences, driving startups across home plate and scoring massive returns. However, they only will take a swing at the perfect pitch.

This one-hour Panel Discussion will highlight 5 - 10 top Life Science Venture Investors willing to take aggressive swings at the most exciting life science startups.

Each panelist will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Join us for Inning 5 of the Bullpen virtual meeting series entitled “Angel Funding.”

Angels are the leadoff investors that pitchers face in the life sciences game. We heard what compels Angels to divinely invest early in promising technologies and people.

This one-hour Panel Discussion highlighted top Angel Investors willing to get the game started for some the world’s most exciting life science startups.

Each panelist shared their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Join us for Inning 6 of the Bullpen virtual meeting series entitled “Venture Funding.”

Hour 1: Panel Discussion

Venture Investors swing for the fences, driving startups across home plate and scoring massive returns. However, they only will take a swing at the perfect pitch.

This one-hour Panel Discussion highlighted top Venture Investors willing to take aggressive swings at the most exciting life science startups.

Each panelist shared their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Join us for Inning 7 of the Bullpen virtual meeting series entitled “7: Strategic Funding.”

Hour 1: Panel Discussion

Strategic Investors are seasoned experts that bring value to the strategy in play for the entities they support. Their investment may come in many different forms: seed funding, collaborations, licensing and M&A…just to name a few.

This one-hour Panel Discussion highlighted top Strategic Investors who take a calculated approach to funding the most exciting life science startups. Each panelist shared their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Join us for Inning 8 of the Bullpen virtual meeting series entitled “8: Exits: M&A and IPO.”

Hour 1: Panel Discussion

In the end, the scoreboard is what matters. How your company exits matters to you, your investors and your partners. Set your vision on the endgame with help from the Bullpen.

This one-hour Panel Discussion highlighted top operators, brokers, investors and buyers who move life science startups across home plate. Each panelist will share their recent exits, the pathways they followed to get it done, deal structures, and 12-month outlook.

Join us for Inning 9 of the Bullpen virtual meeting series entitled “9: Pitch Competition.”

Join this two-hour virtual pitch event featuring 50+ Bullpen Members and their technologies in four distinct categories: Drug, Device, Diagnostic & Digital. This will be the final virtual meeting before we meet the following week in San Diego for BIO 2024 June 2 - 6.